HomeCompareKRDXF vs MRK

KRDXF vs MRK: Dividend Comparison 2026

KRDXF yields 2.27% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 KRDXF wins by $58.0K in total portfolio value· pulled ahead in Year 5
10 years
KRDXF
KRDXF
● Live price
2.27%
Share price
$328.47
Annual div
$7.45
5Y div CAGR
48.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$114.8K
Annual income
$42,752.63
Full KRDXF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — KRDXF vs MRK

📍 KRDXF pulled ahead of the other in Year 5

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodKRDXFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, KRDXF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
KRDXF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

KRDXF
Annual income on $10K today (after 15% tax)
$192.82/yr
After 10yr DRIP, annual income (after tax)
$36,339.74/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, KRDXF beats the other by $28,011.32/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of KRDXF + MRK for your $10,000?

KRDXF: 50%MRK: 50%
100% MRK50/50100% KRDXF
Portfolio after 10yr
$85.8K
Annual income
$26,275.39/yr
Blended yield
30.63%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

KRDXF
Analyst Ratings
1
Buy
Consensus: Buy
Altman Z
11.3
Piotroski
7/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

KRDXF buys
0
MRK buys
0
No recent congressional trades found for KRDXF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricKRDXFMRK
Forward yield2.27%2.76%
Annual dividend / share$7.45$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR48.3%32.7%
Portfolio after 10y$114.8K$56.8K
Annual income after 10y$42,752.63$9,798.13
Total dividends collected$87.3K$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyBuy

Year-by-year: KRDXF vs MRK ($10,000, DRIP)

YearKRDXF PortfolioKRDXF Income/yrMRK PortfolioMRK Income/yrGap
1$11,036$336.42$11,206$366.19$170.00MRK
2$12,324$514.59$12,650$502.35$326.00MRK
3$13,983$796.39$14,407$694.19$424.00MRK
4$16,214$1,252.38$16,585$967.82$371.00MRK
5← crossover$19,361$2,012.75$19,342$1,363.89+$19.00KRDXF
6$24,048$3,331.21$22,913$1,947.19+$1.1KKRDXF
7$31,466$5,734.56$27,662$2,823.89+$3.8KKRDXF
8$44,068$10,399.65$34,159$4,173.35+$9.9KKRDXF
9$67,339$20,186.50$43,337$6,308.80+$24.0KKRDXF
10$114,806$42,752.63$56,776$9,798.13+$58.0KKRDXF

KRDXF vs MRK: Complete Analysis 2026

KRDXFStock

Kardex Holding AG provides intralogistics solutions; and supplies automated storage solutions and materials handling systems worldwide. The company operates in two segments, Kardex Remstar and Kardex Mlog. The Kardex Remstar segment develops, produces, and maintains dynamic storage and retrieval systems. The Kardex Mlog segment offers integrated material handling systems and automated high bay warehouses. The company provides vertical buffer, carousel, and lift, as well as horizontal carousel modules; heavy duty units; office solutions; stacker cranes; AutoStore; pick and place robotics; conveyor systems; software and control solutions; and accessories. Its products are used in automated storage and retrieval systems, buffering and sequencing, order fulfillment, controlled environment, document storage, and general contractor applications. Kardex Holding AG is headquartered in Zurich, Switzerland.

Full KRDXF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this KRDXF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

KRDXF vs SCHDKRDXF vs JEPIKRDXF vs OKRDXF vs KOKRDXF vs MAINKRDXF vs JNJKRDXF vs ABBVKRDXF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.